Parse Biosciences
WA - SeattleBiotechnology
Focus: Parse Biosciences is a single-cell sequencing technology company focused on enabling oncology research and development through advanced genomic tools. The company operates as a pre-revenue or early-stage biotech with a platform-first business model rather than a pipeline-driven therapeutics approach.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
15
Should You Work at Parse Biosciences?
AI assessmentParse is a high-risk, high-potential-impact opportunity best suited for early-career professionals seeking deep expertise in genomics infrastructure and commercial biotech rather than traditional drug development tracks.
Why Work Here
- Core competency in single-cell sequencing positions the company at the intersection of high-growth oncology research tools and precision medicine infrastructure
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Recent News · Parse Biosciences(1)
Help build intelligence for Parse Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.